Trial Profile
Prospective single-centre study investigating the impact of telaprevir therapy adherence in patients on the on the viral response according to the IL28B (rs8099917) genotype in Hepatitis C patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Dec 2015 New trial record